SCHEMBL6769826

SCHEMBL6769826

O=C(O)c1ccc(CCc2ccncc2)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAPRT Q6XQN6 1/20 0.64
NAMPT P43490 1/20 0.54
TBXAS1 P24557 2/20 0.53
ALDH1A1 P00352 1/20 0.52
RARB P10826 2/20 0.50
HDAC6 Q9UBN7 2/20 0.50
HDAC1 Q13547 1/20 0.50
TP53 P04637 1/20 0.50
TSHR P16473 1/20 0.50
HDAC2 Q92769 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
CYP17A1 P05093 1/20 0.49
P2RX3 P56373 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
NPC1 O15118 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
PPARA Q07869 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3896488 0.98 NAPRT (0.61) NAPRTNAMPTTBXAS1ALDH1A1RARB
SCHEMBL10638830 0.92 NAPRT (0.59) NAPRTNAMPTTBXAS1ALDH1A1RARB
SCHEMBL5350293 0.92 NAPRT (0.59) NAPRTNAMPTTBXAS1ALDH1A1RARB
SCHEMBL18906031 0.88 HDAC1 (0.65) NAPRTNAMPTALDH1A1HDAC6HDAC1
SCHEMBL70166 0.87 TSHR (0.67) NAPRTALDH1A1RARBHDAC1TP53
Terephthalic Acid SCHEMBL4612225 0.87 TSHR (0.67) NAPRTALDH1A1RARBHDAC1TP53
Hydrochloric Acid SCHEMBL7132238 0.84 TSHR (0.63) NAPRTALDH1A1RARBHDAC1TP53
SCHEMBL10639390 0.82 NAPRT (0.57) NAPRTNAMPTTBXAS1ALDH1A1HDAC6
SCHEMBL10639379 0.82 NAPRT (0.57) NAPRTNAMPTTBXAS1ALDH1A1HDAC6
SCHEMBL27536266 0.82 CYP17A1 (0.71) HDAC6HDAC1HDAC2HDAC8CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6825181-B1 ORALLY ADMINISTRATED TO EXHIBIT A STRONG ANTICOAGULANT EFFECT BY INHIBITING ACTIVATED BLOOD- COAGULATION FACTOR X AJINOMOTO CO., INC. (JP) 2004-11-30 US disclosed
CN-1302292-A Aminoisoquinoline derivatives AJINOMOTO KK (JP) 2001-07-04 CN disclosed
EP-1065200-A1 AMINOISOQUINOLINE DERIVATIVES Ajinomoto Co., Inc. (JP) 2001-01-03 EP disclosed